Anthony Hayes Insider Trading $SPEX AIkido Pharma Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony Hayes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony Hayes. Anthony Hayes is CEO in AIkido Pharma Inc. ($SPEX) and CHIEF EXECUTIVE OFFICER in SPHERIX INC ($SPEX) and Director in SPHERIX INC ($SPEX) and 10% Owner in Hoth Therapeutics, Inc. ($HOTH) and Director in Hoth Therapeutics, Inc. ($HOTH).
Anthony Hayes in AIkido Pharma Inc.
Trading Symbol: SPEXIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Anthony Hayes: CEO, Director, CHIEF EXECUTIVE OFFICER
Holdings: 78,430 shares
Current Value: $96,469
Latest Transaction: May 04 2021
$SPEX Market Capitalization: $5.74M
$SPEX Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Anthony Hayes in AIkido Pharma Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.99 | 10,000 | 9,900 | 78,430 | 68.4 K to 78.4 K (+14.61 %) |
Apr 30 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.99 | 10,000 | 9,900 | 68,430 | 58.4 K to 68.4 K (+17.11 %) |
Apr 23 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.93 | 10,000 | 9,300 | 58,430 | 48.4 K to 58.4 K (+20.65 %) |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | Hayes Anthony | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | Hayes Anthony | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Nov 20 2018 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.88 | 8,000 | 7,040 | 52,183 | 44.2 K to 52.2 K (+18.11 %) |
Nov 20 2018 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.90 | 2,000 | 1,800 | 44,183 | 42.2 K to 44.2 K (+4.74 %) |
Jun 07 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Option Exercise | A | 1.02 | 3,947 | 4,026 | 65,787 | |
Jun 07 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 1.00 | 1,000 | 999 | 4,214 | 3.2 K to 4.2 K (+31.11 %) |
May 30 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 1.04 | 1,000 | 1,040 | 42,183 | 41.2 K to 42.2 K (+2.43 %) |
May 26 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.97 | 2,000 | 1,940 | 41,183 | 39.2 K to 41.2 K (+5.10 %) |
May 26 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Payment of Exercise | F | 1.11 | 23,287 | 25,849 | 37,183 | 60.5 K to 37.2 K (-38.51 %) |
May 26 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Sell | D | 0.00 | 59,256 | 0 | 60,470 | 119.7 K to 60.5 K (-49.49 %) |
May 26 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Grant | A | 0.00 | 118,512 | 0 | 119,726 | 1.2 K to 119.7 K (+9,762.11 %) |
May 25 2017 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.96 | 2,000 | 1,920 | 3,214 | 1.2 K to 3.2 K (+164.74 %) |
May 24 2016 | SPEX | SPHERIX INC | Hayes Anthony | Director | Option Exercise | A | 1.98 | 75,000 | 148,500 | 132,893 | |
Apr 30 2015 | SPEX | SPHERIX INC | Hayes Anthony | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.79 | 100,000 | 179,000 | 1,100,000 |
Page: 1